Top Buy
| Security | Buy | Sell | Buy (1W) | Sell (1W) ▲ | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Davita Inc. | 4 | 0 | 1 | 0 | €131.85 | €124.89 | -5.280% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.10 | €3.70 | 236.976% |
| Merit Medical Systems | 17 | 0 | 0 | 0 | €76.50 | €86.90 | 13.591% |
| CONMED Corp. | 11 | 1 | 0 | 0 | €67.00 | €106.18 | 58.477% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €103.00 | €124.85 | 21.211% |
| Myriad Genetics | 5 | 3 | 0 | 0 | €21.60 | €23.08 | 6.839% |
| Neurocrine Bioscience | 32 | 0 | 1 | 0 | €126.60 | €140.87 | 11.269% |
| Bio-Techne Corp. | 10 | 0 | 0 | 0 | €71.00 | €75.94 | 6.952% |
| Amedisys Inc. | 14 | 0 | 0 | 0 | €83.50 | €92.26 | 10.491% |
| United Therapeutics | 21 | 0 | 1 | 0 | €269.10 | €288.66 | 7.269% |
| Exelixis Inc. | 18 | 0 | 0 | 0 | €20.32 | €26.01 | 27.984% |
| Arrowhead Pharmaceuticals Inc. | 17 | 2 | 1 | 0 | €24.16 | €54.74 | 126.589% |
| Alnylam Pharmace. | 36 | 0 | 0 | 0 | €149.85 | €236.30 | 57.690% |
| Halozyme Therapeutics Inc. | 18 | 0 | 0 | 0 | €46.26 | €49.59 | 7.188% |
| Insulet Corp. | 17 | 0 | 0 | 0 | €187.25 | €216.46 | 15.600% |
| Amicus Therapeutics Inc. | 7 | 0 | 0 | 0 | €9.85 | €17.64 | 79.063% |
| Masimo Corp. | 8 | 1 | 0 | 0 | €122.70 | €147.56 | 20.261% |
| Ensign Group Inc. | 9 | 0 | 0 | 0 | €111.00 | €116.99 | 5.399% |
| PTC Therapeutics Inc. | 15 | 8 | 0 | 0 | €34.00 | €41.51 | 22.096% |
| Agios Pharmaceuticals Inc. | 7 | 0 | 0 | 0 | €43.60 | €48.75 | 11.811% |
| Xencor Inc. | 14 | 1 | 4 | 0 | €19.40 | €31.70 | 63.384% |
| Ultragenyx Pharmaceutical Inc. | 22 | 1 | 1 | 0 | €36.60 | €85.51 | 133.638% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €76.50 | €79.00 | 3.268% |
| Blueprint Medicines Corp | 1 | 0 | 0 | 0 | €98.58 | - | - |
| Novocure Ltd | 1 | 1 | 0 | 0 | €19.94 | - | - |